Side effects of methylphenidate in childhood cancer survivors: A randomized placebo-controlled trial

Pediatrics

Volumn 124, Issue 1, 2009, Pages 226-233

  Conklin, Heather M ^a   Lawford, Joanne ^a   Jasper, Bruce W ^a   Morris, E Brannon ^a   Howard, Scott C ^a   Ogg, Susan W ^a   Wu, Shengjie ^a   Xiong, Xiaoping ^a   Khan, Raja B ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Brain tumor; Leukemia; Methylphenidate; Side effects; Stimulant

Indexed keywords

ANTINEOPLASTIC AGENT; METHYLPHENIDATE; PLACEBO;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGITATION; ARTICLE; ATTENTION DEFICIT DISORDER; ATTENTION DISTURBANCE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CAREGIVER; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONFUSION; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; EXCITABILITY; FEMALE; HUMAN; HYPERKINESIA; HYPERTENSION; INSOMNIA; INTELLIGENCE QUOTIENT; IRRITABILITY; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; MENTAL INSTABILITY; NAUSEA; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SIDE EFFECT; SYMPTOM; TACHYCARDIA; THORAX PAIN; TIC; VOMITING;

ADOLESCENT; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COGNITION DISORDERS; COMORBIDITY; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; METHYLPHENIDATE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SURVIVORS;

EID: 67649574749     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-1855     Document Type: Article

References (24)

1. Moleski M. Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Arch Clin Neuropsychol. 2000;15(7):603-630 (Pubitemid 30750703)
2. Mulhern RK, Butler RW. Neurocognitive sequelae of childhood cancers and their treatment. Pediatr Rehab. 2004;7(1):1-14 (Pubitemid 38160053)
3. Ris MD, Noll RB. Long-term neurobehavioral outcome in pediatric brain-tumor patients: review and methodological critique. J Clin Exp Neuropsychol. 1994;16(1):21-42 (Pubitemid 24051075)
4. Gadow KD. Pediatric psychopharmacotherapy: a review of recent research. J Child Psychol Psychiatry. 1992;33(1):153-195
5. Barkley RA. A review of stimulant drug research with hyperactive children. J Child Psychol Psychiatry. 1977;18(2):137-165 (Pubitemid 8092156)
6. Conklin HM, Khan RB, Reddick WE, et al. Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial. J Pediatr Psychol. 2007;32(9):1127-1139 (Pubitemid 47622295)
7. Mulhern RK, Khan RB, Kaplan S, et al. Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. J Clin Oncol. 2004;22(23):4795-4803 (Pubitemid 41185091)
8. Thompson SJ, Leigh L, Christensen R, et al. Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. J Clin Oncol. 2001;19(6):1802-1808 (Pubitemid 32230883)
9. Hewitt M, Weiner SL, Simone JV. Childhood Cancer Survivorship: Improving Care and Quality of Life. Washington, DC: National Academic Press; 2003:90-127
10. Hudson MM. Survivors of childhood cancer: coming of age. Hematol Oncol Clin North Am. 2008;22(2):211-231
11. Weiss G, Hechtmann LT. Medication treatment of ADHD. In: Weiss G, Hechtmann LT, eds. Hyperactive Children Grown Up. 2nd ed. New York, NY: Guildford Press; 1993:348-365
12. Barkley RA, McMurray MB, Edelbrock CS, et al. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics. 1990;86(2):184-192 (Pubitemid 20238848)
13. Rapport MD, Moffit C. Attention deficit/hyperactivity disorder and methylphenidate: a review of height-weight, cardiovascular, and somatic complaint side effects. Clin Psychol Rev. 2002;22(8):1107-1131
14. Weber P, Lütschg J. Methylphenidate treatment. Pediatr Neurol. 2002;26(4):261-266 (Pubitemid 34462901)
15. Ahmann PA, Waltonen SJ, Olson KA, et al. Placebo-controlled evaluation of Ritalin side effects. Pediatrics. 1993;91(6):1101-1106 (Pubitemid 23165784)
16. Efron D, Jarman F, Barker M. Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial. Pediatrics. 1997;100(4):662-666 (Pubitemid 27425991)
17. Fine S, Johnston C. Drug and placebo side effects in methylphenidate- placebo trial for attention deficit hyperactivity disorder. Child Psychiatry Hum Dev. 1993;24(1):25-30 (Pubitemid 23259834)
18. DeLong R, Friedman H, Gustafson K, et al. Methylphenidate in neuropsychological sequelae of radiotherapy and chemotherapy of childhood brain tumors and leukemia. J Child Neurol. 1992;7(4):462-463
19. Charach A, Ickowicz A, Schacher R. Stimulant treatment over five years: adherence, effectiveness, and adverse events. J Am Acad Child Adolesc Psychiatry. 2004;43(5):559-567 (Pubitemid 38812367)
20. Barkley RA. Hyperactive Children: A Handbook for Parents. New York, NY: Guildford Press; 1981
21. Gibson AP, Bettinger TL, Patel NC, Crismon ML. Atomoxetine versus stimulants for treatment of attention deficit/hyperactivity disorder. Ann Pharmacother. 2006;40(6):1134-1142 (Pubitemid 43886972)
22. Mohammadi MR, Akhondzade S. Pharmacotherapy of attention-deficit/ hyperactivity disorder: nonstimulant medication approaches. Expert Rev Neurother. 2007;7(2):195-201 (Pubitemid 46434167)
23. Wolraich ML, McGuin L, Doffing M. Treatment of attention deficit hyperactivity disorder in children and adolescents: safety considerations. Drug Saf. 2007;30(1):17-26 (Pubitemid 46072355)
24. Butler RW, Copeland DR, Fairclough DL, et al. A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. J Consult Clin Psychol. 2008;76(3):367-378 (Pubitemid 351822338)